Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors

Chimeric antigen receptor (CAR)‐T cell therapy is a transformative treatment against advanced malignancies. Unfortunately, once administrated in vivo, CAR‐T cells become out of artificial control, and fierce response to CAR‐T therapy may cause severe adverse events, represented by cytokine‐release s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyue, Meng, Fanyan, Li, Xiang, Xue, Luxin, Chen, Anni, Qiu, Yuling, Zhang, Zhifan, Li, Lin, Liu, Fengcen, Li, Yishan, Sun, Zhichen, Chu, Yanhong, Xu, Ruihan, Yu, Lixia, Shao, Jie, Tian, Manman, Qian, Xiaoping, Liu, Qin, Liu, Baorui, Li, Rutian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131841/
https://www.ncbi.nlm.nih.gov/pubmed/36755195
http://dx.doi.org/10.1002/advs.202205044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131841/
https://www.ncbi.nlm.nih.gov/pubmed/36755195
http://dx.doi.org/10.1002/advs.202205044

Ejemplares similares